UK 396082

Drug Profile

UK 396082

Alternative Names: TAFI inhibitor; UK-396,082

Latest Information Update: 01 Jun 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pfizer
  • Class Amino acids; Antithrombotics; Imidazoles
  • Mechanism of Action Carboxypeptidase U inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pulmonary fibrosis; Thrombosis

Most Recent Events

  • 31 Mar 2010 Phase-I clinical trials in Thrombosis in Belgium (PO)
  • 07 Apr 2006 Phase-I clinical trials in Thrombosis in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top